Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for SiBone (SIBN : NSDQ)

• Company Description    SI-BONE Inc. is a medical device company which developed the iFuse Implant System(R) for minimally invasive surgical treatment of the sacroiliac joint dysfunction. SI-BONE Inc. is based in Santa Clara, California. Number of Employees: 349

• Price / Volume Information    Yesterday's Closing Price: $15.36 Daily Weekly Monthly 20 Day Moving Average: 368,546 shares Shares Outstanding: 43.14 (millions) Market Capitalization: $662.65 (millions) Beta: 0.81 52 Week High: $20.05 52 Week Low: $11.70 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 0.99% 0.35% 12 Week -2.17% -6.91% Year To Date 9.56% -5.19%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 471 EL CAMINO REAL SUITE 101 - SANTA CLARA,CA 95050 USA ph: 408-207-0700 fax: - investors@si-bone.com http://si-bone.com

• General Corporate Information    Officers Laura A. Francis - Chief Executive Officer Jeffrey W. Dunn - Chairman Anshul Maheshwari - Chief Financial Officer John G. Freund - Director Jeryl L. Hilleman - Director Peer Information SiBone (ABMD) SiBone (DMDS) SiBone (CPWY.) SiBone (EQUR) SiBone (ECIA) SiBone (FMS) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED INSTRUMENTS Sector: Medical CUSIP: 825704109 SIC: 3841 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/10/25 Share - Related Items Shares Outstanding: 43.14 Most Recent Split Date: (:1) Beta: 0.81 Market Capitalization: $662.65 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.14 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-0.59 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/10/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 3.84 Price/Cash Flow: - Price / Sales: 3.58 EPS Growth vs. Year Ago Period: 36.36% vs. Previous Quarter: 6.67% Sales Growth vs. Year Ago Period: 21.67% vs. Previous Quarter: 2.83% ROE 09/30/25 - - 06/30/25 - -14.20 03/31/25 - -16.00 ROA 09/30/25 - - 06/30/25 - -10.38 03/31/25 - -11.69 Current Ratio 09/30/25 - - 06/30/25 - 8.38 03/31/25 - 8.53 Quick Ratio 09/30/25 - - 06/30/25 - 7.00 03/31/25 - 7.26 Operating Margin 09/30/25 - - 06/30/25 - -12.83 03/31/25 - -15.03 Net Margin 09/30/25 - - 06/30/25 - -12.83 03/31/25 - -15.03 Pre-Tax Margin 09/30/25 - - 06/30/25 - -12.83 03/31/25 - -15.03 Book Value 09/30/25 - - 06/30/25 - 4.00 03/31/25 - 3.93 Inventory Turnover 09/30/25 - - 06/30/25 - 1.30 03/31/25 - 1.38 Debt-to-Equity 09/30/25 - - 06/30/25 - 0.21 03/31/25 - 0.21 Debt-to-Capital 09/30/25 - - 06/30/25 - 17.25 03/31/25 - 17.50

Powered by Zacks Investment Research ©